Mike Kelliher is a director of Capricor Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Mar 24 | ARDX Ardelyx | Common Stock | Grant | Acquire A | No | No | 0 | 160,000 | 0.00 | 160,000 |
25 Mar 24 | ARDX Ardelyx | Stock Option Common Stock | Grant | Acquire A | No | No | 7.7 | 205,000 | 1.58 mm | 205,000 |
2 Jan 24 | CAPR Capricor Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.12 | 30,000 | 153.60 k | 30,000 |
2 Jan 24 | CAPR Capricor Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.12 | 4,730 | 24.22 k | 4,730 |
2 Jan 24 | CAPR Capricor Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.12 | 890 | 4.56 k | 890 |
2 Jan 24 | CAPR Capricor Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.12 | 29,250 | 149.76 k | 29,250 |
1 Sep 23 | CAPR Capricor Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.61 | 115,000 | 760.15 k | 115,000 |